Kan, S., Koido, S., Okamoto, M., Hayashi, K., Ito, M., Kamata, Y., . . . Homma, S. (2015). Up-regulation of HER2 by gemcitabine enhances the antitumor effect of combined gemcitabine and trastuzumab emtansine treatment on pancreatic ductal adenocarcinoma cells. BMC Cancer.

Kan, Shin, Shigeo Koido, Masato Okamoto, Kazumi Hayashi, Masaki Ito, Yuko Kamata, Hideo Komita, Eijiro Nagasaki, and Sadamu Homma. "Up-regulation of HER2 By Gemcitabine Enhances the Antitumor Effect of Combined Gemcitabine and Trastuzumab Emtansine Treatment On Pancreatic Ductal Adenocarcinoma Cells." BMC Cancer 2015.

Kan, Shin, et al. "Up-regulation of HER2 By Gemcitabine Enhances the Antitumor Effect of Combined Gemcitabine and Trastuzumab Emtansine Treatment On Pancreatic Ductal Adenocarcinoma Cells." BMC Cancer 2015.